Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,430 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review.
Li R, Yu K, Li C · Asia Pac J Clin Nutr · 2018Meta-Analysis, Systematic Review
- Association between antihypertensive treatment and adverse events: systematic review and meta-analysis.
Albasri A, Hattle M, Koshiaris C, et al. · BMJ · 2021Meta-Analysis, Research Support, Non-U.S. Gov't
- Gout.
Underwood M · BMJ Clin Evid · 2008Systematic Review
- Effects of dietary factors on hyperuricaemia and gout: a systematic review and meta-analysis of observational studies.
Chi X, Cen Y, Yang B, et al. · Int J Food Sci Nutr · 2024Systematic Review, Meta-Analysis
- 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Neogi T, Jansen TL, Dalbeth N, et al. · Arthritis Rheumatol · 2015Consensus Statement, Research Support, N.I.H., Extramural
- Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
Dalbeth N, Billington K, Doyle A, et al. · Arthritis Rheumatol · 2019Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Gout.
Underwood M · BMJ Clin Evid · 2015Systematic Review
- Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review.
Schlesinger N, Pillinger MH, Simon LS, et al. · Arthritis Res Ther · 2023Systematic Review, Research Support, Non-U.S. Gov't
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.
White WB, Saag KG, Becker MA, et al. · N Engl J Med · 2018Comparative Study, Equivalence Trial
- Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China.
Sun J, Wang Y, Cheng Y, et al. · Arthritis Rheumatol · 2025Randomized Controlled Trial, Clinical Trial, Phase III
- Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Mackenzie IS, Ford I, Nuki G, et al. · Lancet · 2020Multicenter Study, Randomized Controlled Trial
- Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis.
Li YJ, Chen LR, Yang ZL, et al. · Clin Rheumatol · 2023Systematic Review, Network Meta-Analysis
- Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR, Wortmann RL, et al. · N Engl J Med · 2005Clinical Trial, Phase III, Comparative Study
- Febuxostat for treating chronic gout.
Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME · Cochrane Database Syst Rev · 2012Meta-Analysis, Research Support, Non-U.S. Gov't
- Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.
De Filippo O, D'Ascenzo F, Iannaccone M, et al. · Cardiovasc Diabetol · 2023Meta-Analysis, Systematic Review
- The effects of aerobic exercise on body composition in overweight and obese patients with gout: a randomized, open-labeled, controlled trial.
Jia E, Zhu H, Geng H, et al. · Trials · 2022Randomized Controlled Trial
- Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials.
Yang XH, Zhang BL, Cheng Y, et al. · Ann Med · 2024Systematic Review, Meta-Analysis
- Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.
Helget LN, Davis-Karim A, O'Dell JR, et al. · Am J Kidney Dis · 2024Equivalence Trial, Multicenter Study
- Association between gout and cancers: A systematic review and meta-analysis.
Tian L, Wang Y, Zhang Y, et al. · Medicine (Baltimore) · 2024Systematic Review, Meta-Analysis
- A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
Botson JK, Saag K, Peterson J, et al. · Arthritis Rheumatol · 2023Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Systemic corticosteroids for acute gout.
Janssens HJ, Lucassen PL, Van de Laar FA, et al. · Cochrane Database Syst Rev · 2008Meta-Analysis, Systematic Review
- Analysis of Metabolites in Gout: A Systematic Review and Meta-Analysis.
Li Y, Han X, Tong J, et al. · Nutrients · 2023Meta-Analysis, Systematic Review
- Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
Doherty M, Jenkins W, Richardson H, et al. · Lancet · 2018Multicenter Study, Randomized Controlled Trial
- A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares.
Saag KG, Khanna PP, Keenan RT, et al. · Arthritis Rheumatol · 2021Clinical Trial, Phase II, Equivalence Trial
- Gout, hyperuricemia, and male reproductive health: a systematic review and meta-analysis.
Mao J, Xu M, Tang Y, et al. · Front Immunol · 2026Systematic Review, Meta-Analysis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.